HAIYA PATEL: Open Payments
NPI 1124792189 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 18 payments from 9 companies in 2025. Trend: 2023 $869 · 2024 $747 · 2025 $494
Food & beverage: $494
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 6 | $178 |
| United Therapeutics Corporation | 2 | $138 |
| PFIZER INC. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| BridgeBio Pharma, Inc. | 1 | $17 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $6 |
Products named: UPTRAVI, ELIQUIS, JARDIANCE, Kerendia, LEQVIO, CAMZYOS, Attruby, Tyvaso.
Industry payments across AL — which companies pay providers there.
